Aurora Cannabis Inc (ACB) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.030x

Based on the latest financial reports, Aurora Cannabis Inc (ACB) has a cash flow conversion efficiency ratio of 0.030x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$17.00 Million ≈ $12.30 Million USD) by net assets (CA$567.83 Million ≈ $410.76 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Aurora Cannabis Inc - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how Aurora Cannabis Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Aurora Cannabis Inc carry for a breakdown of total debt and financial obligations.

Aurora Cannabis Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Aurora Cannabis Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Olimpo Real Estate SA
MC:YORE
0.026x
BLS E-Services Limited
NSE:BLSE
N/A
Zur Shamir Holdings Ltd
TA:ZUR
-0.213x
Saksoft Limited
NSE:SAKSOFT
0.099x
Jakarta Setiabudi Internasional
JK:JSPT
0.063x
Ampco-Pittsburgh Corporation
NYSE:AP
0.084x
Boa Safra Sementes S.A
SA:SOJA3
0.015x
Isu Chemical Co Ltd
KO:005950
0.147x

Annual Cash Flow Conversion Efficiency for Aurora Cannabis Inc (2007–2025)

The table below shows the annual cash flow conversion efficiency of Aurora Cannabis Inc from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see Aurora Cannabis Inc market cap and net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 CA$608.59 Million
≈ $440.25 Million
CA$16.00 Million
≈ $11.58 Million
0.026x +123.10%
2024-03-31 CA$601.87 Million
≈ $435.38 Million
CA$-68.51 Million
≈ $-49.56 Million
-0.114x +49.18%
2023-03-31 CA$517.14 Million
≈ $374.09 Million
CA$-115.82 Million
≈ $-83.78 Million
-0.224x -34.53%
2022-03-31 CA$662.35 Million
≈ $479.14 Million
CA$-110.27 Million
≈ $-79.77 Million
-0.166x -61.10%
2021-03-31 CA$2.04 Billion
≈ $1.47 Billion
CA$-210.58 Million
≈ $-152.33 Million
-0.103x +35.77%
2020-03-31 CA$2.13 Billion
≈ $1.54 Billion
CA$-342.14 Million
≈ $-247.50 Million
-0.161x -267.42%
2019-03-31 CA$4.39 Billion
≈ $3.18 Billion
CA$-192.25 Million
≈ $-139.07 Million
-0.044x +16.18%
2018-03-31 CA$1.56 Billion
≈ $1.13 Billion
CA$-81.67 Million
≈ $-59.08 Million
-0.052x +14.50%
2017-03-31 CA$218.93 Million
≈ $158.37 Million
CA$-13.38 Million
≈ $-9.68 Million
-0.061x +94.62%
2016-03-31 CA$5.96 Million
≈ $4.31 Million
CA$-6.77 Million
≈ $-4.90 Million
-1.136x -30.96%
2015-03-31 CA$3.83 Million
≈ $2.77 Million
CA$-3.32 Million
≈ $-2.40 Million
-0.867x -21.62%
2014-03-31 CA$1.35 Million
≈ $979.00K
CA$-965.11K
≈ $-698.14K
-0.713x -10.54%
2013-03-31 CA$694.20K
≈ $502.17K
CA$-447.84K
≈ $-323.96K
-0.645x -149.38%
2012-03-31 CA$1.07 Million
≈ $777.31K
CA$-277.98K
≈ $-201.09K
-0.259x -28.90%
2011-03-31 CA$1.37 Million
≈ $992.94K
CA$-275.48K
≈ $-199.28K
-0.201x -11055.39%
2010-03-31 CA$1.71 Million
≈ $1.24 Million
CA$-3.08K
≈ $-2.23K
-0.002x +92.54%
2009-03-31 CA$1.62 Million
≈ $1.17 Million
CA$-39.04K
≈ $-28.24K
-0.024x +53.43%
2008-03-31 CA$1.69 Million
≈ $1.22 Million
CA$-87.26K
≈ $-63.12K
-0.052x -247.38%
2007-03-31 CA$430.22K
≈ $311.22K
CA$15.11K
≈ $10.93K
0.035x --

About Aurora Cannabis Inc

TO:ACB Canada Drug Manufacturers - Specialty & Generic
Market Cap
$193.63 Million
CA$267.67 Million CAD
Market Cap Rank
#16661 Global
#515 in Canada
Share Price
CA$4.72
Change (1 day)
+1.07%
52-Week Range
CA$4.33 - CA$8.66
All Time High
CA$1808.40
About

Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers pharmaceutical-grade cannabis products; medical and consumer cannabis products; and engages in the propagation of vegetables … Read more